Skip to main content

Table 1 Baseline characteristics of all the subjects

From: The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity

Variables

CAD (n = 120)

nonCAD (n = 90)

P

DM(n = 37)

nonDM (n = 173)

P

Male (%)

63.6

57.3

NS

59.8

61.3

NS

Age (years)

63.96 ± 7.85

63.09 ± 8.25

NS

64.32 ± 7.36

63.41 ± 8.18

NS

BMI (kg/m2)

24.17 ± 3.92

24.42 ± 3.02

NS

25.47 ± 3.40

24.00 ± 3.54

0.024

TG (mg/dl)

128.43 ± 71.74

129.32 ± 79.72

NS

147.92 ± 91.23

124.00 ± 69.97

NS

TC (mg/dl)

145.40 ± 35.96

158.16 ± 39.83

0.005

146.95 ± 40.22

151.97 ± 37.51

NS

HDL-C (mg/dl)

40.60 ± 10.05

44.08 ± 11.21

0.028

39.06 ± 9.28

42.92 ± 10.83

NS

LDL-C (mg/dl)

88.16 ± 30.16

97.06 ± 31.32

0.021

88.17 ± 31.32

92.81 ± 30.94

NS

apoAI (g/L)

1.08 ± 0.20

1.17 ± 0.25

0.008

1.08 ± 0.20

1.12 ± 0.23

NS

apoB (g/L)

0.85 ± 0.25

0.89 ± 0.26

NS

0.89 ± 0.28

0.86 ± 0.25

NS

hsCRP (mg/L)

4.93 (1.26–13.44)

2.36 (1.17–7.00)

NS

5.12 (1.62–8.28)

3.23 (1.18–11.51)

NS

FFA (mmol/L)

0.52 ± 0.29

0.44 ± 0.27

0.047

0.57 ± 0.29

0.46 ± 0.28

0.045

Statin (%)

55.5

3.8

< 0.0001

35.1

32.9

NS

Smoking (%)

46.4

30.5

0.036

37.8

40.0

NS

HF (%)

72.7

42.7

< 0.0001

72.9

57.2

NS

  1. Values are expressed as mean ± SD or median (interquartile range). CAD coronary artery disease, DM diabetes mellitus, BMI body mass index, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, apoAI apolipoprotein AI, apoB apolipoprotein B, hsCRP high sensitivity C reactive protein, FFA free fatty acid, HF heart failure